November 05, 2024 / 10:29 IST
Reported Consolidated quarterly numbers for Sun Pharma Advanced Research Company are:Net Sales at Rs 12.86 crore in September 2024 down 39.28% from Rs. 21.18 crore in September 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 107.33 crore in September 2024 down 24.2% from Rs. 86.42 crore in September 2023.
EBITDA stands negative at Rs. 102.87 crore in September 2024 down 23.97% from Rs. 82.98 crore in September 2023.
Sun Pharma Adv shares closed at 205.13 on November 01, 2024 (NSE) and has given -4.26% returns over the last 6 months and -15.11% over the last 12 months.
| Sun Pharma Advanced Research Company | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Sep'24 | Jun'24 | Sep'23 | | Net Sales/Income from operations | 12.86 | 16.81 | 21.18 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 12.86 | 16.81 | 21.18 | | EXPENDITURE | | Consumption of Raw Materials | 8.31 | 4.53 | 6.47 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 38.48 | 54.26 | 30.71 | | Depreciation | 3.16 | 3.14 | 3.18 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 68.98 | 51.38 | 75.47 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -106.07 | -96.50 | -94.65 | | Other Income | 0.04 | 1.56 | 8.49 | | P/L Before Int., Excpt. Items & Tax | -106.03 | -94.94 | -86.16 | | Interest | 1.14 | 0.56 | 0.26 | | P/L Before Exceptional Items & Tax | -107.17 | -95.50 | -86.42 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -107.17 | -95.50 | -86.42 | | Tax | 0.16 | 0.40 | -- | | P/L After Tax from Ordinary Activities | -107.33 | -95.90 | -86.42 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -107.33 | -95.90 | -86.42 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -107.33 | -95.90 | -86.42 | | Equity Share Capital | 32.45 | 32.45 | 32.45 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -3.31 | -2.96 | -2.66 | | Diluted EPS | -3.31 | -2.96 | -2.66 | | EPS After Extra Ordinary | | Basic EPS | -3.31 | -2.96 | -2.66 | | Diluted EPS | -3.31 | -2.96 | -2.66 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
